Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX) -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (960)	6/26/2002 9:05:11 PM
From: NeuroInvestment	Read Replies (1) \| Respond to of 1834

Wilder: Over the past six months, I've had most of the hubris pretty much excised from my psyche. We're all just 'pip-squeaks' on the BioBus. Miljenko: Your record is close to 80%--whenever I respond to a comment of yours, you then ask me for information which falls into a certain category--that when I have asked companies for it, they tell me (in these words sometimes) ;'if we told you, we'd have to kill you.' So, no--I do vaguely recall omega oriented discussions from a while back: I am quite sure I have never been offered a subtype by subtype binding profile. And if I had, and I told you...then...oh never mind. Harry Tracy NeuroInvestment www.neuroinvestment.com